Comparative evaluation of the Vitek-2 Compact and Phoenix systems for rapid identification and antibiotic susceptibility testing directly from blood cultures of Gram-negative and Gram-positive isolates

Diagnostic Microbiology and Infectious Disease

Volumn 72, Issue 1, 2012, Pages 20-31

  Gherardi, Giovanni ^a   Angeletti, Silvia ^a   Panitti, Miriam ^a   Pompilio, Arianna ^b   Di Bonaventura, Giovanni ^b   Crea, Francesca ^a   Avola, Alessandra ^a   Fico, Laura ^a   Palazzo, Carlo ^a   Sapia, Genoveffa Francesca ^a   Visaggio, Daniela ^a   Dicuonzo, Giordano ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Blood cultures; Direct inoculation method; Gram negative; Gram positive; Phoenix; Vitek

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CLINDAMYCIN; COLISTIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; OXACILLIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ACCURACY; ANALYTICAL ERROR; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOMATION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOOD CULTURE; CITROBACTER BRAAKII; CITROBACTER FREUNDII; CONTROLLED STUDY; CORYNEBACTERIUM STRIATUM; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; INOCULATION; INTERMETHOD COMPARISON; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MICROCOCCUS LUTEUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PANTOEA AGGLOMERANS; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; RAOULTELLA PLANTICOLA; RELIABILITY; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HOMINIS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BLOOD; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 83055180721     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2011.09.015     Document Type: Article

References (52)

1. Anderson D.J., Engemann J.J., Harrell L.J., Carmeli Y., Reller L.B., Kaye K.S. Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae. Antimicrob. Agents Chemother. 2006, 50:1715-1720.
2. Barenfanger J., Graham D.R., Kolluri L., Sangwan G., Lawhorn J., Drake C.A., Verhulst S.J., Peterson R., Moja L.B., Ertmoed M.M., Moja A.B., Shevlin D.W., Vautrain R., Callahan C.D. Decreased mortality associated with prompt gram staining of blood cultures. Am. J. Clin. Pathol. 2008, 130:870-876.
3. Beekmann S.E., Diekema D.J., Chapin K.C., Doern G.V. Effects of rapid detection of bloodstream infections on length of hospitalization and hospital charges. J. Clin. Microbiol. 2003, 41:3119-3125.
4. Blot S., Vandewoude K., De Bacquer D., Colardyn F. Nosocomial bacteremia caused by antibiotic-resistant Gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin. Infect. Dis. 2002, 34:1600-1606.
5. Bruins M.J., Bloembergen P., Ruijs G.J., Wolfhagen M.J. Identification and susceptibility testing of Enterobacteriaceae and Pseudomonas aeruginosa by direct inoculation from positive Bactec blood culture bottles into Vitek 2. J. Clin. Microbiol. 2004, 42:7-11.
6. Chen J.R., Lee S.Y., Yang B.H., Lu J.J. Rapid identification and susceptibility testing using the Vitek 2 system using culture fluids from positive BacT/Alert blood cultures. J. Microbiol. Immunol. Infect. 2008, 41:259-264.
7. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing; 20th informational supplement M100-S20 2010, CLSI, Wayne, PA.
8. Coleman R.W., Rodondi L.C., Kaubisch S., Granzella N.B., O'Hanley P.D. Cost-effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989. Am. J. Med. 1991, 90:439-444.
9. Cosgrove S.E., Kaye K.S., Eliopoulous G.M., Carmeli Y. Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species. Arch. Intern. Med. 2002, 162:185-190.
10. de Cueto M., Ceballos E., Martinez-Martinez L., Perea E.J., Pascual A. Use of positive blood cultures for direct identification and susceptibility testing with the Vitek 2 system. J. Clin. Microbiol. 2004, 42:3734-3738.
11. Eveillard M., Lemarie C., Cottin J., Hitoto H., Mahaza C., Kempf M., Joly-Guillou M.L. Assessment of the usefulness of performing bacterial identification and antimicrobial susceptibility testing 24 h a day in a clinical microbiology laboratory. Clin. Microbiol. Infect. 2010, 16:1084-1089.
12. Ferroni A., Suarez S., Beretti J.J., Dauphin B., Bille E., Meyer J., Bougnoux M.E., Alanio A., Berche P., Nassif X. Real-time identification of bacteria and Candida species in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 2010, 48:1542-1548.
13. Fitzpatrick F., Turley M., Humphreys H., Smyth E. An after-hours clinical liaison blood culture service-is it worth it?. Clin. Microbiol. Infect. 2004, 10:917-921.
14. Fraser A., Paul M., Almanasreh N., Tacconelli E., Frank U., Cauda R., Borok S., Cohen M., Andreassen S., Nielsen A.D., Leibovici L. Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay. Am. J. Med. 2006, 119:970-976. TREAT Study Group.
15. Funke G., Funke-Kissling P. Use of the BD Phoenix automated microbiology system for direct identification and susceptibility testing of gram-negative rods from positive blood cultures in a three-phase trial. J. Clin. Microbiol. 2004, 42:1466-1470.
16. Garrouste-Orgeas M., Timsit J.F., Tafflet M., Misset B., Zahar J.R., Soufir L., Lazard T., Jamali S., Mourvillier B., De Lassence Y.A., Azoulay E., Cheval C., Descorps-Declere A., Adrie C., Costa de Beauregard M.A., Carlet J. Excess risk of death from intensive care unit acquired nosocomial bloodstream infections: a reappraisal. Clin. Infect. Dis. 2006, 42:1118-1126.
17. Goldmann D.A., Weinstein R.A., Wenzel R.P., Tablan O.C., Duma R.J., Gaynes R.P., Schlosser J., Martone W.J. Strategies to prevent and control the emergence and spread of antimicrobial- resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 1996, 275:234-240.
18. Hansen W.L.J., Beuving J., Bruggeman C.A., Wolffs P.F.G. Molecular probes for diagnosis of clinically relevant bacterial infections in blood cultures. J. Clin. Microbiol. 2010, 48:4432-4438.
19. Hirschman S.Z., Meyers B.R., Bradnury K., Mehl B., Gendelman S., Kimelblatt B. Use of antimicrobial agents in a university teaching hospital. Evolution of a comprehensive control programme. Ann. Intern. Med. 1988, 148:2001-2007.
20. Ibrahim E.H., Sherman G., Ward S., Fraser V.J., Kollef M.H. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000, 118:146-155.
21. Jordan J.A., Jones-Laughner J., Durso M.B. Utility of pyrosequencing in identifying bacteria directly from positive blood culture bottles. J. Clin. Microbiol. 2009, 47:368-372.
22. Kang C.I., Kim S.H., Park W.B., Lee K.D., Kim H.B., Kim E.C., Oh M.D., Choe K.W. Bloodstream infections caused by antibiotic-resistant Gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob. Agents Chemother. 2005, 49:760-766.
23. Kelesidis T., Tsiodras S. Staphylococcus intermedius is not only a zoonotic pathogen, but may also cause skin abscesses in humans after exposure to saliva. Int. J. Infect. Dis. 2010, 14:e838-e841.
24. Kim S.H., Park W.B., Lee K.D., Kang C.I., Bang J.W., Kim H.B., Kim E.C., Oh M.D., Choe K.W. Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J. Antimicrob. Chemother. 2004, 54:489-497.
25. Kollef M.H. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin. Infect. Dis. 2000, 31:S131-S138.
26. Kumar A., Roberts D., Wood K.E., Light B., Parrillo J.E., Sharma S., Suppes R., Feinstein D., Zanotti S., Taiberg L., Gurka D., Kumar A., Cheang M. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit. Care. Med. 2006, 34:1589-1596.
27. Leibovici L., Shraga I., Drucker M., Konigsberger H., Samra Z., Pitlik S.D. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J. Intern. Med. 1998, 244:379-386.
28. Lin M.Y., Weinstein R.A., Hota B. Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia. Antimicrob. Agents Chemother. 2008, 52:3188-3194.
29. Ling T.K., Liu Z.K., Cheng A.F. Evaluation of the Vitek 2 system for rapid direct identification and susceptibility testing of Gram-negative bacilli from positive blood cultures. J. Clin. Microbiol. 2003, 41:4705-4707.
30. Lodise T.P., McKinnon P.S., Swiderski L., Rybak M.J. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin. Infect. Dis. 2003, 36:1418-1423.
31. Lupetti A., Barnini S., Castagna B., Nibbering P.H., Campa M. Rapid identification and antimicrobial susceptibility testing of Gram-positive cocci in blood cultures by direct inoculation into the BD Phoenix system. Clin. Microbiol. Infect. 2010, 16:986-991.
32. McGowan J.E. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance?. Infect. Control. Hosp. Epidemiol. 1994, 15:478-483.
33. Micek S.T., Lloyd A.E., Ritchie D.J., Reichley R.M., Fraser V.J., Kollef M.H. Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob. Agents Chemother. 2005, 49:1306-1311.
34. Morrell M., Fraser V.J., Kollef M.H. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob. Agents Chemother. 2005, 49:3640-3645.
35. Parta M., Goebel M., Matloobi M., Stager C., Musher D.M. Identification of methicillin-resistant or methicillin-susceptible Staphylococcus aureus in blood cultures and wound swabs by GeneXpert. J. Clin. Microbiol. 2009, 47:1609-1610.
36. Peters R.P., van Agtmael M.A., Danner S.A., Savelkoul P.H., Vandenbroucke-Grauls C.M. New developments in the diagnosis of bloodstream infections. Lancet. Infect. Dis. 2004, 4:751-760.
37. Peters R.P., Savelkoul P.H., Simoons-Smit A.M., Danner S.A., Vandenbroucke-Grauls C.M., van Agtmael M.A. Faster identification of pathogens in positive blood cultures by fluorescence in situ hybridization in routine practice. J. Clin. Microbiol. 2006, 44:119-123.
38. Prodhom G., Bizzini A., Durussel C., Bille J., Greub G. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for direct bacterial identification from positive blood culture pellets. J. Clin. Microbiol. 2010, 48:1481-1483.
39. Putnam L.R., Howard W.J., Pfaller M.A., Koontz F.P., Jones R.N. Accuracy of the Vitek system for antimicrobial susceptibility testing Enterobacteriaceae bloodstream infection isolates: use of direct inoculation from Bactec 9240 blood culture bottles. Diagn. Microbiol. Infect. Dis. 1997, 28:101-104.
40. Qian Q., Tang Y.W., Kolbert C.P., Torgerson C.A., Hughes J.G., Vetter E.A., Harmsen W.S., Montgomery S.O., Cockerill I.I.I.F.R., Persing D.H. Direct identification of bacteria from positive blood cultures by amplification and sequencing of the 16S rRNA gene: evaluation of BACTEC 9240 instrument true-positive and false-positive results. J. Clin. Microbiol. 2001, 39:3578-3582.
41. Quesada M.D., Gimenez M., Molinos S., Fernandez G., Sanchez M.D., Rivelo R., Ramirez A., Banqu G., Ausina V. Performance of VITEK-2 Compact and overnight MicroScan panels for direct identification and susceptibility testing of Gram-negative bacilli from positive FAN BacT/ALERT blood culture bottles. Clin. Microbiol. Infect. 2010, 16:137-140.
42. Rodrguez-Bao J., Milln A.B., Domnguez M.A., Borraz C., Gonzlez M.P., Almirante B., Cercenado E., Padilla B., Pujol M. Impact of inappropriate empirical therapy for sepsis due to health care-associated methicillin-resistant Staphylococcus aureus. J. Infect. 2009, 58:131-137. GEIH/GEMARA/REIPI.
43. Seifert H. The clinical importance of microbiological findings in the diagnosis and management of bloodstream infections. Clin. Infect. Dis. 2009, 48:S238-S245.
44. Stevenson L.G., Drake S.K., Murray P.R. Rapid identification of bacteria in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 2010, 48:444-447.
45. Tenover F.C. Rapid detection and identification of bacterial pathogens using novel molecular technologies: infection control and beyond. Clin. Infect. Dis. 2007, 44:418-423.
46. Tissari P., Zumla A., Tarkka E., Mero S., Savolainen L., Vaara M., Aittakorpi A., Laakso S., Lindfors M., Piiparinen H., Mki M., Carder C., Huggett J., Gant V. Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: an observational study. Lancet 2010, 375:224-230.
47. Towns M.L., Jarvis W.R., Hsueh P.R. Guidelines on blood cultures. J. Microbiol. Immunol. Infect. 2010, 43:347-349.
48. Tumbarello M., Spanu T., Di Bidino R., Marchetti M., Ruggeri M., Trecarichi E.M., De Pascale G., Proli E.M., Cauda R., Cicchetti A., Fadda G. Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-lactamase production and inadequate initial antibiotic therapy. Antimicrob. Agents Chemother. 2010, 54:4085-4091.
49. Waites K.B., Brookings E.S., Moser S.A., Zimmer B.L. Direct susceptibility testing with positive BacT/Alert blood cultures by using MicroScan overnight and rapid panels. J. Clin. Microbiol. 1998, 36:2052-2056.
50. Wallet F., Nseir S., Baumann L., Herwegh S., Sendid B., Boulo M., Roussel-Delvallez M., Durocher A.V., Courcol R.J. Preliminary clinical study using a multiplex real-time PCR test for the detection of bacterial and fungal DNA directly in blood. Clin. Microbiol. Infect. 2010, 16:774-779.
51. Wellinghausen N., Wirths B., Essig A., Wassill L. Evaluation of the Hyplex BloodScreen multiplex PCR-enzyme-linked immunosorbent assay system for direct identification of Gram-positive cocci and Gram-negative bacilli from positive blood cultures. J. Clin. Microbiol. 2004, 42:3147-3152.
52. Zaragoza R., Artero A., Camarena J.J., Sancho S., Gonzalez R., Nogueira J.M. The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin. Microbiol. Infect. 2003, 9:412-418.